Figure 2.
Figure 2. ROC curves based on presence of cardiac involvement. (A) BNP in all patients (n = 249) with a threshold higher than 81 pg/mL. (B) NT-proBNP in all patients (n = 249) with a threshold higher than 288 pg/mL. (C) BNP in patients with eGFR at least 30 mL/min/1.73 m2 (n = 203) with a threshold higher than 81 pg/mL. (D) NT-proBNP in patients with eGFR at least 30 mL/min/1.73 m2 (n = 203) with a threshold higher than 288 pg/mL. (E) BNP in patients with eGFR less than 30 mL/min/1.73 m2 (n = 46) with a threshold higher than 472 pg/mL. (F) NT-proBNP in patients with eGFR less than 30 mL/min/1.73 m2 (n = 46) with a threshold higher than 2930 pg/mL.

ROC curves based on presence of cardiac involvement. (A) BNP in all patients (n = 249) with a threshold higher than 81 pg/mL. (B) NT-proBNP in all patients (n = 249) with a threshold higher than 288 pg/mL. (C) BNP in patients with eGFR at least 30 mL/min/1.73 m2 (n = 203) with a threshold higher than 81 pg/mL. (D) NT-proBNP in patients with eGFR at least 30 mL/min/1.73 m2 (n = 203) with a threshold higher than 288 pg/mL. (E) BNP in patients with eGFR less than 30 mL/min/1.73 m2 (n = 46) with a threshold higher than 472 pg/mL. (F) NT-proBNP in patients with eGFR less than 30 mL/min/1.73 m2 (n = 46) with a threshold higher than 2930 pg/mL.

Close Modal

or Create an Account

Close Modal
Close Modal